Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Mylan Inc (MYL)

2014-10-30@17:23:30 ET
After Yesterday's Rally of 2.99% Shares Could Potentially Pullback (PSM)

2014-10-30@17:22:59 ET
Mylan Rises 2.99% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-10-30@17:12:25 ET
Deal snapshot: ABBOTT TO SELL DEVELOPED GENERICS BUSINESS TO MYLAN IN USD5.3BN DEAL (MTN)

2014-10-30@16:05:00 ET
Mylan Third Quarter 2014 Adjusted Diluted EPS Increases 41% to $1.16 (PRN)

2014-10-30@12:48:00 ET
(PRN)

2014-10-30@08:35:15 ET
Sanofi-Aventis had the Lowest Relative Performance in the Pharmaceuticals Industry (SNY, MDCO, MYL, ENDP, NVS) (F70)

2014-10-29@08:57:27 ET
Potential Mylan Laboratories (MYL) Trade Has 3.81% Downside Protection (FBM)

2014-10-27@12:56:45 ET
Mylan Laboratories (MYL) Showing Bullish Technicals With Support At $50.07 (FBM)

2014-10-27@08:01:00 ET
(PRN)

2014-10-24@08:56:45 ET
Salix Pharmaceuticals had the Lowest Relative Performance in the Pharmaceuticals Industry (SLXP, VRX, LLY, MYL, RPRX) (F70)

2014-10-23@08:29:46 ET
Medicines Co had the Lowest Relative Performance in the Pharmaceuticals Industry (MDCO, MYL, SLXP, ABT, AGN) (F70)

2014-10-22@12:25:39 ET
Mylan Laboratories (MYL) Trading Near $50.12 Support Level (FBM)

2014-10-22@12:23:25 ET
Shares of Mylan Under Pressure, Down 2.3% (F77)

2014-10-21@11:04:31 ET
Mylan (MYL) Breaks Through Resistance at $50.91 (F79)

2014-10-21@09:00:00 ET
Equities Updates on Pharma Industry - Mylan, Horizon Pharma, Hospira, VIVUS, and Endocyte (PRN)